BELLEMIN JEAN-MARC (Chief Financial Officer) exercised options at IOVANCE BIOTHERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/4/2025ACC: 0001104659-25-056432
Officer· Chief Financial Officer
Since Dec 2020
-4.46K
Net shares
Net seller
$7.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
8.79K acquired · 13.25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.79K
Price / share
—
Trade value
—
% of position
15.6%
6/2/2025
56.20K→64.99K
Common Stock
Direct
Shares
−4.46K
Price / share
$1.76
Trade value
$7.86K
% of position
6.9%
6/2/2025
64.99K→60.53K
Total
Net shares
+4.33K
Net value
-$7.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2025 | M · Option Exercise | +8.79K | — | — | 15.6% | 56.20K | 64.99K |
| Common Stock Direct | 6/2/2025 | F · Tax Withholding | −4.46K | $1.76 | $7.86K | 6.9% | 64.99K | 60.53K |
| Total | +4.33K | -$7.86K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
8.79K shares
Shares
−8.79K
Strike price
Held after
61.53K
Exercisable
—
6/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock8.79K shares | 6/2/2025 | M · Option Exercise | −8.79K | — | 61.53K |